Asthma: diagnosis, monitoring and management in nursing practice
British Journal of Nursing · 19.11.2026 · 35 (21) · 1034-1040
DOI: 10.12968/bjon.2025.0453 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Nursing, erschienen am 19.11.2026. Verfasst von Eleanor Brown und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Asthma is one of the most common chronic respiratory conditions in the UK, affecting both children and adults. It is characterised by airway inflammation, variable symptoms, and reversible airflow limitation. This article provides a nursing-focused overview of asthma, exploring the definition, altered pathophysiology, diagnosis, and both pharmacological and non-pharmacological management. It highlights the importance of accurate assessment, early differentiation from other respiratory conditions, and the use of structured diagnostic tools within national guidance. Education, adherence support, and awareness of excessive reliever use are identified as key nursing priorities. By following national and local guidelines, promoting the use of combination and anti-inflammatory therapies, and providing holistic, person-centred education, nurses can improve symptom control, reduce preventable hospital admissions, and enhance quality of life for individuals and families living with asthma.
Zitieren
APA
Brown, E., Hill, B., & Mitchell, A. (2026). Asthma: diagnosis, monitoring and management in nursing practice. British Journal of Nursing, 35(21), 1034-1040. https://doi.org/10.12968/bjon.2025.0453
Vancouver
Brown E, Hill B, Mitchell A. Asthma: diagnosis, monitoring and management in nursing practice. British Journal of Nursing. 2026;35(21):1034-1040. doi:10.12968/bjon.2025.0453
BibTeX
@article{Brown2026,
author = {Brown, Eleanor and Hill, Barry and Mitchell, Aby},
title = {Asthma: diagnosis, monitoring and management in nursing practice},
journal = {British Journal of Nursing},
year = {2026},
volume = {35},
number = {21},
pages = {1034--1040},
doi = {10.12968/bjon.2025.0453}
}
EUVIMED